DK0547422T3 - Stabile pulverformige vitamin- og/eller carotenoid-præparater og fremgangsmåde til deres fremstilling - Google Patents

Stabile pulverformige vitamin- og/eller carotenoid-præparater og fremgangsmåde til deres fremstilling

Info

Publication number
DK0547422T3
DK0547422T3 DK92120456.6T DK92120456T DK0547422T3 DK 0547422 T3 DK0547422 T3 DK 0547422T3 DK 92120456 T DK92120456 T DK 92120456T DK 0547422 T3 DK0547422 T3 DK 0547422T3
Authority
DK
Denmark
Prior art keywords
preparation
methods
carotenoid preparations
stable powdery
powdery vitamin
Prior art date
Application number
DK92120456.6T
Other languages
Danish (da)
English (en)
Inventor
Joachim U Dr Schneider
Udo Dr Rheude
Wolfgang Dr Bewert
Horst Dr Schumacher
Guenter Dr Gaus
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Application granted granted Critical
Publication of DK0547422T3 publication Critical patent/DK0547422T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK92120456.6T 1991-12-14 1992-12-01 Stabile pulverformige vitamin- og/eller carotenoid-præparater og fremgangsmåde til deres fremstilling DK0547422T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4141351A DE4141351A1 (de) 1991-12-14 1991-12-14 Stabile pulverfoermige vitamin- und/oder carotinoid-praeparate und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
DK0547422T3 true DK0547422T3 (da) 1996-04-01

Family

ID=6447112

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92120456.6T DK0547422T3 (da) 1991-12-14 1992-12-01 Stabile pulverformige vitamin- og/eller carotenoid-præparater og fremgangsmåde til deres fremstilling

Country Status (7)

Country Link
US (1) US5356636A (fr)
EP (1) EP0547422B1 (fr)
JP (1) JP2519008B2 (fr)
CA (1) CA2083754C (fr)
DE (2) DE4141351A1 (fr)
DK (1) DK0547422T3 (fr)
IL (1) IL103866A (fr)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL110139A0 (en) * 1993-06-28 1994-10-07 Howard Foundation Pharmaceutically-active antioxidants
CN1067548C (zh) * 1994-01-21 2001-06-27 上海第六制药厂 β－胡萝卜素或类胡萝卜素微型胶囊的制备及其应用
DE4405545A1 (de) * 1994-02-22 1995-08-31 Dietl Hans Fettlösliche Vitamine enthaltende Zubereitung zur oralen Applikation
DE19539574A1 (de) * 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
JPH09124470A (ja) 1995-10-26 1997-05-13 Suntory Ltd 抗ストレス組成物
US5747544A (en) * 1995-10-31 1998-05-05 Applied Food Biotechnology, Inc. Method of using pure 3R-3'R stereoisomer of zeaxanthin to treat or prevent retinal degeneration in humans
CA2188983C (fr) 1995-10-31 2001-02-27 Kevin M. Garnett Stereoisomere 3r-3'r purs de zeaxanthine pour le traitement de la degenerescence maculaire chez l'homme
US5854015A (en) * 1995-10-31 1998-12-29 Applied Food Biotechnology, Inc. Method of making pure 3R-3'R stereoisomer of zeaxanthin for human ingestion
US5827652A (en) 1995-10-31 1998-10-27 Applied Food Biotechnology, Inc. Zeaxanthin formulations for human ingestion
US5948443A (en) * 1996-02-23 1999-09-07 Medical Doctor's Research Institute, Inc. Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease
JP3555640B2 (ja) * 1996-05-10 2004-08-18 ライオン株式会社 天然カロチノイドを包含した多芯型構造のマイクロカプセル並びに錠剤、食品用及び医薬品用配合剤
GB9616910D0 (en) * 1996-08-12 1996-09-25 Dunnett Mark A method of increasing ›-alanylihistidine pipetide synthesis and accumulation in humans and animals
DE19637517A1 (de) * 1996-09-13 1998-03-19 Basf Ag Herstellung von pulverförmigen, kaltwasserdispergierbaren Carotinoid-Zubereitungen und die Verwendung der neuen Carotinoid-Zubereitungen
DE19642359A1 (de) * 1996-10-14 1998-04-16 Basf Ag Stabile Emulsionen und Trockenpulver von Mischungen fettlöslicher Vitamine, deren Herstellung und Verwendung
DE19649062A1 (de) * 1996-11-27 1998-05-28 Basf Ag Flüssige, mit Öl mischbare Carotinoid-Zubereitungen
US20030203036A1 (en) 2000-03-17 2003-10-30 Gordon Marc S. Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
DE19703469C2 (de) * 1997-01-31 2003-10-30 Wolfgang Von Rhein Verfahren zur Herstellung eines oxidationsgeschützten Vitamin-C-Präparats
US5976568A (en) * 1997-02-21 1999-11-02 Medical Doctors' Research Institute, Inc. Modular system of dietary supplement compositions for optimizing health benefits and methods
US6007856A (en) * 1997-08-08 1999-12-28 The Procter & Gamble Company Oil-in-water dispersions of β-carotene and other carotenoids stable against oxidation prepared from water-dispersible beadlets having high concentrations of carotenoid
PT1033132E (pt) * 1997-10-20 2005-09-30 Dainippon Pharmaceutical Co Composicao de farmaco rapidamente soluvel
EP0913177A1 (fr) 1997-11-03 1999-05-06 Roche Diagnostics GmbH Procédé pour produire des produits amorphe, sec comprenant de la matière biologique active par séchage convectif, spécialement söchage par pulvérisation
JP4027535B2 (ja) * 1998-05-26 2007-12-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 脂溶性薬物を含有した粉末
BR9914070A (pt) * 1998-09-25 2001-10-16 Kemin Ind Inc Método de proteção de compostos lábeis ao oxigênio e/ou ao calor, e contra a degradação por agentes oxidantes e/ou iniciadores de radicais livres, e, ração para um organismo
US6146671A (en) * 1999-05-08 2000-11-14 Kemin Industries, Inc. Method and protecting heat-or oxygen-labile compounds to preserve activity and bioavailability
DE60014255T2 (de) * 1999-07-06 2005-11-03 Dsm Ip Assets B.V. Zusammensetzung, die fettlösliche Substanzen in einer Kohlenhydratmatrix enthält
US6582721B1 (en) 1999-09-17 2003-06-24 Alcon, Inc. Stable carotene-xanthophyll beadlet compositions and methods of use
US6328995B1 (en) * 1999-09-24 2001-12-11 Basf Aktiengesellschaft Stable vitamin and/or carotenoid products in powder form and process for their production
US6989161B2 (en) 2000-06-12 2006-01-24 Access Business Group International Llc Phytonutrient nutritional supplement
US7438936B2 (en) * 2000-06-12 2008-10-21 Access Business Group International Llc Dietary supplement and related method
US6511675B2 (en) 2000-06-12 2003-01-28 Access Business Group International, Llc Composition and method for correcting a dietary phytochemical deficiency
US7416749B2 (en) * 2000-06-12 2008-08-26 Access Business Group International Llc Dietary supplement and related method
US7939115B2 (en) * 2000-06-12 2011-05-10 Access Business Group International Llc Dietary supplement and related method
US7575761B2 (en) 2000-06-30 2009-08-18 Novartis Pharma Ag Spray drying process control of drying kinetics
US7691406B2 (en) * 2000-10-27 2010-04-06 ZeaVision LLC. Zeaxanthin formulations for human ingestion
DE10064387A1 (de) 2000-12-21 2002-06-27 Basf Ag Verfahren zur Herstellung von Trockenpulvern eines oder mehrerer Sauerstoff-haltiger Carotinoide
US7595378B2 (en) 2001-06-13 2009-09-29 Genmab A/S Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
MX246154B (es) * 2001-08-23 2007-06-04 Dsm Ip Assets Bv Nuevas composiciones estabilizadas de carotenoides.
US6663900B2 (en) * 2002-02-01 2003-12-16 Kemin Foods, Lc Microcapsules having high carotenoid content
US6974592B2 (en) * 2002-04-11 2005-12-13 Ocean Nutrition Canada Limited Encapsulated agglomeration of microcapsules and method for the preparation thereof
US6936279B2 (en) * 2002-06-18 2005-08-30 Zeavision Llc Microcrystalline zeaxanthin with high bioavailability in oily carrier formulations
US7794764B2 (en) * 2002-10-15 2010-09-14 Mars Incorporated Preservation of process sensitive ingredients in an energy food product by product partitioning
WO2004004485A2 (fr) * 2002-07-08 2004-01-15 Mars, Incorporated Barre energetique a gout ameliore
EP1559433A4 (fr) * 2002-10-22 2009-11-04 Dainippon Sumitomo Pharma Co Composition stabilisee
US8088363B2 (en) 2002-10-28 2012-01-03 Zeavision Llc Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin
ES2347045T3 (es) * 2002-11-04 2010-10-25 Ocean Nutrition Canada Limited Microcapsulas que tienen multiples cortezas, y metodo para su preparacion.
US9192586B2 (en) 2003-03-10 2015-11-24 Zeavision Llc Zeaxanthin formulations with additional ocular-active nutrients, for protecting eye health and treating eye disorders
EP1433387A1 (fr) * 2002-12-26 2004-06-30 Adisseo France S.A.S. Granulés solides comprenant des carotenoides
US20060110517A1 (en) 2003-01-31 2006-05-25 Reinhold Carle Novel compositions comprising carotenoids
CN1764439B (zh) * 2003-03-27 2010-05-26 帝斯曼知识产权资产管理有限公司 制备交联明胶珠粒的方法
JP4716982B2 (ja) * 2003-04-03 2011-07-06 ディーエスエム アイピー アセッツ ビー．ブイ． 脂溶性活性成分の粉末状配合物
US20070082066A1 (en) * 2003-05-07 2007-04-12 Gierhart Dennis L Use of zeaxanthin to reduce light hyper-sensitivity, photophobia, and medical conditions relating to light hyper-sensitivity
EP1643845B1 (fr) * 2003-07-15 2011-11-02 DSM IP Assets B.V. Preparations pulverulentes d'ingredients actifs liposolubles
US20060228569A1 (en) * 2003-08-08 2006-10-12 Tadaaki Kojima Production method of substrate with black film and substrate with black film
US7541166B2 (en) * 2003-09-19 2009-06-02 Microfluidic Systems, Inc. Sonication to selectively lyse different cell types
US7941211B2 (en) * 2003-11-17 2011-05-10 Zeavision, Llc. Preloading with macular pigment to improve photodynamic treatment of retinal vascular disorders
DE102004006106A1 (de) * 2004-02-06 2005-08-25 Basf Ag Verfahren zur Herstellung von Trockenpulvern eines oder mehrerer Carotinolde
US20050186307A1 (en) * 2004-02-20 2005-08-25 Axelrod Glen S. Pet food with enhanced nutritional value
ES2549258T3 (es) * 2004-03-18 2015-10-26 Dsm Ip Assets B.V. Composiciones de ácidos grasos poli-insaturados estables a la extrusión para productos alimenticios
ATE392882T1 (de) * 2004-07-09 2008-05-15 Mavi Sud S R L Formulierung auf basis von gelatine-glyzin und carotenoiden
US20060089411A1 (en) * 2004-08-07 2006-04-27 Gierhart Dennis L Treatment of Stargardt's disease and other lipofuscin disorders with combined retinaldehyde inhibitor and zeaxanthin
US8034450B2 (en) * 2005-01-21 2011-10-11 Ocean Nutrition Canada Limited Microcapsules and emulsions containing low bloom gelatin and methods of making and using thereof
DE602006011127D1 (de) * 2005-01-27 2010-01-28 Ocean Nutrition Canada Ltd Fettsäure-benzenediol-derivate sowie herstellungs- und verwendungsverfahren dafür
EP1848729A2 (fr) * 2005-01-27 2007-10-31 Ocean Nutrition Canada Limited Composes de chrome et d'acides gras et leurs procedes de fabrication et d'utilisation
US8592662B2 (en) 2005-02-11 2013-11-26 Kalamazoo Holdings, Inc. Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom
JP2008532492A (ja) * 2005-02-11 2008-08-21 カラマズー・ホールディングス・インコーポレイテッド ゼアキサンチンの過剰蓄積を示すトウガラシ属品種およびそこから得られる産物
ATE492275T1 (de) * 2005-04-15 2011-01-15 Einstein Coll Med Vitamin k zur vorbeugung und behandlung von hautausschlag infolge einer anti-egfr-therapie
US9968120B2 (en) * 2006-05-17 2018-05-15 Dsm Nutritional Products Ag Homogenized formulations containing microcapsules and methods of making and using thereof
WO2007120500A2 (fr) * 2006-04-07 2007-10-25 Ocean Nutrition Canada Ltd. Emulsions et microcapsules contenant des substances a faible tension interfaciale, leurs procedes de fabrication et d'utilisation
EP2040682B1 (fr) * 2006-06-05 2017-07-26 DSM Nutritional Products AG Microcapsules à enveloppes améliorées
US8221809B2 (en) * 2006-06-22 2012-07-17 Martek Biosciences Corporation Encapsulated labile compound compositions and methods of making the same
CA2656613A1 (fr) * 2006-07-03 2008-01-10 Genmab A/S Prevention d'une eruption cutanee sur des patients subissant une therapie anti-egfr
EP2124905B1 (fr) 2007-01-10 2016-09-07 DSM Nutritional Products AG Microcapsules comprenant de la proteine de pois
DE102007015701A1 (de) * 2007-03-19 2008-09-25 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Neue pharmazeutische Zusammensetzungen für die Lipolyse und Verfahren zu deren Herstellung
WO2008157629A1 (fr) * 2007-06-19 2008-12-24 Martek Biosciences Corporation Compositions pour microencapsulation, leurs procédés de fabrication et d'utilisation et produits obtenus à partir de celles-ci
EP2164975B1 (fr) 2007-07-06 2012-02-01 Basf Se Procédé de préparation d'une solution de glucose aqueuse concentrée à partir de maïs
US8815953B2 (en) * 2008-03-13 2014-08-26 Spectrum Pharmaceuticals, Inc. Formulations of vitamin K analogs for topical use
CN101971917A (zh) * 2010-08-14 2011-02-16 格特生物制药（天津）有限公司 一种畜禽用脂溶性维生素功能性饲料添加剂及其制备方法
WO2013148307A1 (fr) 2012-03-27 2013-10-03 3M Innovative Properties Company Particules composites, leurs procédés de fabrication, et articles les comportant
CN103315370B (zh) * 2013-05-24 2015-04-08 肇庆巨元生化有限公司 一种稳定的类胡萝卜素的微囊化方法
CN103284290B (zh) * 2013-05-24 2015-04-08 肇庆巨元生化有限公司 一种良好的类胡萝卜素的微囊化方法
CN112638492A (zh) * 2018-09-28 2021-04-09 陶氏环球技术有限责任公司 烷基醚胺泡沫控制化合物和加工食品的方法
JP2021107340A (ja) * 2019-12-27 2021-07-29 小林製薬株式会社 経口組成物
CN116490080A (zh) * 2020-11-30 2023-07-25 帝斯曼知识产权资产管理有限公司 抗氧化剂含量降低的新制剂及其制造和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB993138A (en) * 1961-11-22 1965-05-26 Pfizer & Co C Improvements in the preparation of vitamin-containing beadlets
DE3307095A1 (de) * 1983-03-01 1984-09-06 Degussa Ag, 6000 Frankfurt Mikrobiologisch hergestellte l-phenylalanin-dehydrogenase, verfahren zu ihrer gewinnung und ihre verwendung
EP0140255B1 (fr) * 1983-10-14 1991-05-15 Sumitomo Pharmaceuticals Company, Limited Injections à libération prolongée
US4863950A (en) * 1985-03-12 1989-09-05 Morganti Pier F Medicinal formulation for promoting keratinogenesis and reducing seborrhea of the face and scalp
DE3610191A1 (de) * 1986-03-26 1987-10-01 Basf Ag Verfahren zur herstellung von feinteiligen, wasserdispergierbaren carotinoid-praeparationen
US4892889A (en) * 1986-11-18 1990-01-09 Basf Corporation Process for making a spray-dried, directly-compressible vitamin powder comprising unhydrolyzed gelatin
ATE64527T1 (de) * 1987-04-06 1991-07-15 Hoffmann La Roche Verfahren zur herstellung von vitaminpraeparaten.
US5153177A (en) * 1991-01-10 1992-10-06 Basf Corporation Process for incorporating a material in a crosslinked gelatin, and product therefrom

Also Published As

Publication number Publication date
JP2519008B2 (ja) 1996-07-31
CA2083754A1 (fr) 1993-06-15
EP0547422A2 (fr) 1993-06-23
JPH0665062A (ja) 1994-03-08
EP0547422B1 (fr) 1996-03-13
EP0547422A3 (en) 1994-05-11
DE59205688D1 (de) 1996-04-18
DE4141351A1 (de) 1993-06-17
IL103866A (en) 1996-12-05
IL103866A0 (en) 1993-04-04
US5356636A (en) 1994-10-18
CA2083754C (fr) 2001-08-14

Similar Documents

Publication Publication Date Title
DK0547422T3 (da) Stabile pulverformige vitamin- og/eller carotenoid-præparater og fremgangsmåde til deres fremstilling
DK56086D0 (da) 11beta-phenylgonaner, deres fremstilling og farmaceutiske praeparaterindeholdende dem
NO893678L (no) Cyklosporinholdige preparater og fremgangsmaate for deres fremstilling.
DK288184D0 (da) 13alfa-alkylgonaner, deres fremstilling og farmaceutiske praeparater indeholdende disse
DK166007C (da) Farvet naeringsmiddelpraeparat, isaer til dekorationsbrug og fremgangsmaade til fremstilling af praeparatet
NO900577D0 (no) Cyklosporinholdige preparater og fremgangsmaate for deres fremstilling.
DK166583C (da) 1-pyrimidinyloxy-3-alkylamino-2-propanoler, deres fremstilling og farmaceutiske praeparater indeholdende disse
DK408786D0 (da) Fremgangsmaade til fremstilling af vitaminforstadier og vitaminer
DK304090A (da) Glycerolderivater, fremgangsmaade til deres fremstilling og terapeutiske praeparater indeholdende disse
DK514989A (da) Enolestere og -ethere af 3-acyl-2-oxindol-1-carboxamider og deres anvendelse til fremstilling af laegemidler
DK261485A (da) Kosmetiske praeparater og fremgangsmaade til deres fremstilling
DK449989A (da) Quinolinderivater, deres fremstilling og laegemidler indeholdende disse derivater
DK299590D0 (da) Phospholipidderivater, fremgangsmaade til deres fremstilling og terapeutiske praeparater indeholdende disse
DK155692D0 (da) Benzofuranylimidazolderivater, fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende disse
DK443186D0 (da) Vitamin d derivater og fremgangsmaade til fremstilling deraf
DK347789D0 (da) Cysteinderivater, fremgangsmaade til fremstilling af dem og farmaceutiske praeparater indeholdende saadanne forbindelser
DK457386A (da) 4-substituerede catechol-derivater, fremgangsmaade til fremstillingderaf og farmaceutiske praeparater indeholdende saadanne derivater
DK9086D0 (da) Naphthalenderivater af benzonorbornen, fremgangsmaade til deres fremstilling og laegemidler og kosmetikpraeparater indeholdende saadanne forbindelser
DK352586A (da) 11-methylen-aestr-15-ener, fremgangsmaader til deres fremstilling og farmaceutiske praeparater indeholdende disse aestrener
DK180588D0 (da) Anti-tumor-virksomme praeparater og fremgangsmaade til deres fremstilling
DK276690D0 (da) Selenophenderivater, fremgangsmaade til deres fremstilling og terapeutiske praeparater indeholdende disse
DK19085D0 (da) Triazolylsubstituerede propanforbindelser, deres fremstilling og farmaceutiske praeparater, som indeholder dem
DK170290D0 (da) Fremgangsmaade til fremstilling af vandoploeseligt primycin og dets komponent samt farmaceutiske praeparater indeholdende dem
NO924563L (no) Benzokinoksaliner, fremgangsmaate for deres fremstilling og farmasoeytiske preparater inneholdende de nevnte forbindelser
DK182089A (da) Fremgangsmaade til fremstilling og pakning af levnedsmiddelprodukter og/eller praeparater og pakning til saadanne produkter og/eller praeparater